The primary objective will be to demonstrate the manufacturing feasibility and safety, and to determine the maximum tolerated dose (MTD) of RNA-LP vaccines in (Stratum 1) adult patients with newly diagnosed GBM (MGMT unmethylated). Funding Source *…
- Investigators
- Marcia B Hodik, Ashley Ghiaseddin
- Ages
- 21 Years - N/A
- Sexes
- All